Bloomberg Television to air segment on Antigen Express’ immunotherapeutic breast cancer vaccine Generex Biotechnology Company today announced that Bloomberg Tv is scheduled to atmosphere a segment on the immunotherapeutic breasts cancer vaccine being produced by it is wholly-owned subsidiary, Antigen Express, Inc. The story covers the business’s novel Ii-Essential Hybrid-centered HER-2/neu Peptide Vaccine , which may be the subject of a continuing Phase 2 clinical research in individuals with HER-2 expressing breasts malignancy. Related StoriesStudy shows uncommon HER2 missense mutations usually do not spread breasts cancer on the ownMD Anderson research reveals why chemotherapy medications not effective for most pancreatic cancers patientsSausages With Antioxidants From Berries TO AVOID CancerThe segment includes an interview by Bloomberg reporter Cali Carlin of Dr.Why me? I was only 36. Please don’t do this if you ask me! I knew all of the crying couldn’t keep me from losing my locks, as I had to take chemotherapy easily wanted to live. So I shaved my locks and also have rocked my baldness ever since – without regrets. I do skip the older me with the very long, blond hair. But I have the same encounter still, and it’s still me inside. I truly think that bald is beautiful. It’s something I think about every time I head into a healthcare facility and see anyone who has lost his / her hair to tumor. They are brave, and they are beautiful.